Originally from:
Oracle Partners Larry Feinberg; “Good luck to those who think there’s money to be made betting against Dr. Frost”
See which stocks are being affected by Social Media
[…]
This article first appeared on Inc.com posted from Peter Economy.I have spent my career in the investment business and have participated in thousands of meetings or calls with managements of public companies. A few times, I have received inside information, and I guarantee that you know when you’ve got it. When I worked at a large mutual fund company, we […]
2015 2nd Quarter Market CommentaryJuly 22, 2015 | Documents and Literature,Insight,News & Press | Editor | 0 CommentOverviewThe fireworks came out just in time for the Fourth of July. The second quarter was relatively sleepy until the end of June when the Greek debt crisis made headlines again. Greece rejected a cash-for-reform proposal by the EU and missed an IMF […]
Ishares Nasdaq Biotechnology Index (IBB) has been on a tear in the last year, outperforming the NASDAQ and S&P 500 by multiples greater than 3x and 6x, respectively. This rapid appreciation has spurted chatter of a bubble forming in the biotech sector. Even US leaders have expressed a difference of opinion. Yellen, for example, stated back in July 2014 that the biotech industry […]
More –
The Google Wake-Up Call
See which stocks are being affected by Social Media
[…]
Anacor Pharmaceuticals (NASDAQ:ANAC)On Monday July 13, 2015 shares of Anacor went up 55%, closing around $131.93 per share after the company announced positive phase 3 results in patients who have atopic dermatitis. There were two phase 3 trials that were testing Anacor’s drug, Crisaborole, for these patients with atopic dermatitis — also known as Eczema. The company wanted to see […]
Would you rather be a have…or a have-not?If you want to be a “have” in this market, you’d better read on because the difference between the haves and the have-nots is growing.And today I’m going to show you exactly how you can profit from inequality in the stock market. You’ll even get a shot at picking up a rock-solid stock […]
It’s old hat that biotech ETFs are beating the stock market. But three are new launches flying under the radar of many investors. BioShares Biotechnology Products (NASDAQ:BBP) holds stocks such as Celgene (NASDAQ:CELG) and Anacor Pharmaceuticals (NASDAQ:ANAC) that have shone of late. Two others focus on businesses in the clinical trial stage.http://news.investors.com/071615-762046-small-new-biotechnology-etfs-are-outperforming-peers.htm?ven=yahoocp&src=aurlled&ven=yahoo
View original –
Is Your Biotech ETF Keeping Up With 3 […]
The Bloomberg Commodity Index tumbled once again today, hitting its lowest level since 2002. Stocks did not. We have seen this kind of ‘deflationary’ boom before and it did not end well…*)As BofAML somewhat mockingly reflected; It’s a deflationary boom. Nasdaq hits all-time high today; CRB breaking down to 2002 lows. Wall St narrative flips from crash to boom/bubble as […]
